Final report: Combination of MPC-6827 with temozolomide for the treatment of patients with metastatic melanoma

Autor:	J. Stephenson, E. A. Swabb, Wen-Jen Hwu, B. A. Evans, Omid Hamid, Wallace Akerley, Margaret K. Yu, G. Mather
Rok vydání:	2010
Předmět:	Oncology Cancer Research medicine.medical_specialty Temozolomide Metastatic melanoma Tolerability business.industry Internal medicine medicine Pharmacology business medicine.drug
Zdroj:	Journal of Clinical Oncology. 28:8531-8531
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2010.28.15_suppl.8531
Popis:	8531 Background: MPC-6827 (Azixa) is a microtubule destabilizing agent. This study was designed to establish the safety and tolerability of MPC-6827 when combined with temozolomide. Methods: Patien...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d87b4768b812a8acbcc631fec50072bc https://doi.org/10.1200/jco.2010.28.15_suppl.8531 Zobrazit plný text záznamu